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Abstract
Background: Home-based HIV testing and counselling (HB-HTC) is frequently used to increase awareness of HIV
status in sub-Saharan Africa. Whereas acceptance of HB-HTC is usually high, testing coverage may remain low due
to household members being absent during the home visits. This study assessed whether two consecutive visits,
one during the week, one on the weekend, increase coverage.
Methods: The study was a predefined nested-study of the CASCADE-trial protocol and conducted in 62 randomly
selected villages and 17 urban areas in Butha-Buthe district, Lesotho. HB-HTC teams visited each village/urban area
twice: first during a weekday, followed by a weekend visit to catch-up for household members absent during the
week. Primary outcome was HTC coverage after first and second visit. Coverage was defined as all individuals who
knew their HIV status out of all household members (present and absent).
Results: HB-HTC teams visited 6665 households with 18,286 household members. At first visit, 69.2 and 75.4% of
household members were encountered in rural and urban households respectively (p < 0.001) and acceptance for
testing was 88.5% in rural and 79.5% in urban areas (p < 0.001), resulting in a coverage of 61.8 and 61.5%,
respectively. After catch-up visit, the HTC coverage increased to 71.9% in rural and 69.4% in urban areas. The
number of first time testers was higher at the second visit (47% versus 35%, p < 0.001). Direct cost per person
tested and per person tested HIV positive were lower during weekdays (10.50 and 335 USD) than during
weekends (20 and 1056 USD).
Conclusions: A catch-up visit on weekends increased the proportion of persons knowing their HIV status from 62
to 71% and reached more first-time testers. However, cost per person tested during catch-up visits was nearly
twice the cost during first visit.
Trial registration: NCT02692027 (prospectively registered on February 21, 2016).
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Background
High coverage of antiretroviral therapy (ART) to achieve
viral suppression in people living with HIV/AIDS is a
cornerstone of the UNAIDS strategy to end AIDS by 2030
and is defined in the 90–90-90 targets [1]. Universal aware-
ness of HIV status through broad HIV testing is the front
door to this strategy [2]. In South-Eastern Africa, the region
most heavily affected by the HIV epidemic, the percentage
of people living with HIV who know their status has been
steadily increasing over the last years and, according to
UNAIDS, by the end of 2017 was estimated 81% [3].
Providing home-based HIV testing and counselling
(HTC) is a well-established approach to reach individuals
who do not seek testing at health facilities and to increase
testing coverage in the population [4, 5]. In a meta-
analysis that included 31 studies of home-based HTC,
pooled uptake – acceptance of HTC – was 82% [6].
However, even where uptake may be high, coverage often
remains low as home-based HTC misses all those individ-
uals who are absent during the home visit. This may par-
ticularly affect working household members and children
and adolescents going to school since most home-based
HTC campaigns are conducted during regular working-
hours. In their meta-analysis, Sharma and colleagues esti-
mated coverage achieved through home-based HTC. Of
the identified 16 studies reporting on HTC coverage and
conducted after 2005, nine were of large scale (> 10′000
individuals) [6]. Coverage rates varied widely from 33% in
a study conducted in Malawi [7] to 96% in study in Kenya
[8]. More recently, the SEARCH project, which used a hy-
brid approach of mobile clinics and home-based testing,
achieved 91 and 87% testing coverage in Ugandan and
Kenyan regions, respectively [9].
Lesotho, a small landlocked country surrounded by
South Africa, has the second-highest HIV prevalence glo-
bally (adult HIV prevalence 23.6 [21.2–24.7]) [10]. In
2014, 63% of adult women and 38% of men reported hav-
ing had an HIV test in the last 12months, and according
to 2017 UNAIDS estimates 72% were aware of their status
in 2016 [11]. In a cluster-randomized trial, home-based
HTC had an acceptance rate of 92.5%. However, this trial
did not assess coverage, and the rather low HIV preva-
lence among those tested through home-based HTC sug-
gests that mostly household members with lower risk of
exposure had been reached in this trial [12].
Here, we report HTC coverage achieved through a new
home-based HTC strategy where households are visited
twice – first on a workday and then on a weekend day in
order to catch household members absent during the week.
Methods
Design
We report the results of a sub-study of the CASCADE-
trial [13]. The here reported sub-study is a predefined
nested study of the published protocol of the CASCADE-
trial [14]. The major objective of this cross-sectional study
is to assess coverage achieved through a two-day home-
based HTC. The first visit always occurred during a work
day. The second visit was strictly on weekends and aimed
at offering HTC to household members who were absent
during the first visit. The home-based HTC campaigns
were conducted in rural and semi-urban neighborhoods
of six catchment areas in Butha-Buthe district in northern
Lesotho. For rural areas, villages were randomly selected
from a list of eligible villages. To be eligible, a village had
to be clearly confined to one of the six catchment areas
and to comprise between 40 and 80 households. Catch-
ment areas of the clinics are defined by the district health
authorities. In Butha-Buthe town, urban neighborhoods
were randomly selected.
Setting
Butha-Buthe is a mostly rural district with an estimated
110,000 habitants, primarily subsistence farmers, mine
workers, or construction and domestic workers in neigh-
boring South Africa. The district has only one small
town (Buthe-Buthe, ca. 25,000 habitants), while the
remaining habitants live in villages scattered over a
partly mountainous surface of 1767 km2. In 2016, the
adult HIV-prevalence (15–49 years) was 17.8% [15]. The
district is served by one public, one missionary hospital
and 10 health centers. Similar to other high prevalence
settings, HTC is provided by lay counsellors [16]. Lay
counsellors are persons who completed at least primary
education and underwent a standardized 10-day training
on how to conduct HTC. They are supervised by a pro-
fessional counsellor with tertiary education. In our study
all participating lay-counsellors were female.
Procedure
Chiefs of the selected villages and urban neighborhoods
were informed prior to the home-visits. From February 22
to July 17, 2016 three teams, each consisting of four lay-
counsellors, one professional counsellor, one nurse and a
driver, visited one village per day. Upon arrival the team
members divided up the village assigning a specific area to
each lay-counsellor. Lay-counsellors then walked from
house to house to propose HTC to all households in their
area. The head of household or a substitute (usually the
oldest household member present) had to provide written
consent before the lay-counsellor could enter. Once inside
and behind closed doors, the lay-counsellor first counted
all members living in the respective household – present
and absent. Every person spending at least two nights per
month in the household was defined as household mem-
ber. This definition was chosen because in Lesotho many
family members work in neighboring South Africa and
return back home only 1 week-end per month. Once
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information about all members was collected, the lay-
counsellor proposed HTC to all individuals who were
present. HTC was performed according to international
and national guidelines [17]. All household members who
were not known to be HIV-positive were eligible for HTC.
As per guidelines, each individual had to sign the National
HTC consent form before being tested. For children below
12 years of age, a caregiver aged ≥21 years had to provide
consent. Household members could choose to test in fam-
ily or separately. Initial testing was done with Alere Deter-
mine™ HIV-1/2. In case of a positive result, Trinity Biotech
Uni-Gold™ was used for confirmatory testing. Once all
who accepted HTC were tested, the lay-counsellor
announced the week-end day he/she would return to
propose HTC to absent household-members. This second
visit was always during the following weekend, based on a
list with households where members had been absent at
first visit. Each lay-counsellor was re-assigned to the same
households she had seen during the first round. Members
absent at first visit but present at the second visit were
proposed HTC. Persons found HIV positive were assessed
for eligibility for the CASCADE-trial as outlined in the
protocol [14]. Those not eligible were assessed by the
nurse and referred to the clinic.
Data and analysis
The major variable of interest was the HTC coverage
achieved in the study areas after first and second visit of
home-based HTC. Coverage was defined as the percentage
of individuals knowing their HIV status after the home
visits (either already known to be HIV infected or tested at
one of the two home-visits during the study) out of all
household members (encountered and not encountered
during the two home-visits). HTC uptake was defined as
follows: number of individuals who accepted HTC over all
household members encountered at home and who were
not known to be HIV positive. In addition to coverage and
uptake we assessed time since last test categorizing clients
into “never tested before”, “tested ≥12 months ago” and
“tested <12 months ago”.
Data-collection was tablet-based using a specifically de-
veloped app (Visible Solutions AG, Switzerland, visibleim-
pact.org). For every household member, the outcome of the
HTC home visit was categorized into “not encountered”,
“encountered, already known to be HIV-positive”, “encoun-
tered, refused HTC” and “encountered, took up HTC”.
Every evening, when the study team had returned to
town, data were uploaded from tablets to a banking-
standard ISO 27001 audited data center and deleted
from the mobile device.
Statistical analysis
Data were summarized with frequencies and percentages
for categorical data and medians and interquartile ranges
(IQR) for continuous data. Categorical data were com-
pared with chi-square tests and continuous data with
Wilcoxon rank sum tests.
Subgroups of apriori interest were children (age < 15
years of age), male adults, and female adults. Univariable
logistic regression models were utilized to test for the
association between these three subgroups and presence at
home, uptake and coverage. Within the three subgroups,
the association between previous testing status and uptake
and HIV prevalence was modeled using logistic regression.
Results are presented with odds ratios (OR) and 95% confi-
dence intervals (CI). For HTC uptake and coverage, we
further stratified analysis by urban versus rural areas. We
further stratified outcome analyses All data analysis was
done using Stata version 14 (StataCorp, College Station,
TX, USA).
Cost considerations
In this article we report the retrospective cost-analysis
considering direct cost of staff, staff training, equipment
and transport while planning and conducting the HTC
campaigns. Transport cost included fuel, vehicle insur-
ance, tire replacement, car servicing and repair but not
the purchase of the vehicle. The sum of all costs was
then divided by the number of persons tested or number
of persons newly tested positive. Cost attributed per item
is reported in the Additional file 1: Table S1.
Results
Participants
From February 22 to July 17, 2016 counsellors visited 62
rural villages and 17 urban areas. Out of a total of 6660 oc-
cupied households, 5 (0.08%) heads of household did not
consent to a household visit. The 3800 consenting rural
households (median 50 (IQR 27–80) per village) had 11,368
household members (median 3, IQR 1–4 per household).
In the urban areas, the 2855 consenting households (me-
dian 121 (IQR 67–273) per urban area) had 6968 house-
hold members (median 2, IQR 1–4 per household).
Coverage after first visit
During the first household visit, 69.2% of the household
members in villages and 75.4% of those in urban areas
were at home (p < 0.001). Among all 13,119 household
members encountered at home during first visit, 1365
(10.4%) were already known to be HIV-infected. Among
the remaining 11,754 who had never tested positive, HTC
uptake was 88.5% in villages and 79.5% in urban areas
(p < 0.001). Overall coverage after first visit was 61.8% in
rural villages and 61.5% in urban areas (p = 0.74).
Coverage after second-visit
Of the 6655 households surveyed during first visit, 2004
(30.1%) had absent members and were re-visited on the
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following weekend. Of the 5217 household members ab-
sent during the first visit, 1890 (36.2%) were encoun-
tered during the second visit. Just over half of these were
children who had mostly been at school (Table 1). Of
the 1890 newly present members at the second visit, 56
were known to be HIV positive. Among those who had
never tested HIV positive, 1647 (90.4%) took up HTC
(urban 84.0%, rural 93.7%, p < 0.001). With the second
visit, overall HTC coverage increased to 71.0% (Fig. 1),
69.4%% in urban and 71.9% in rural areas (p < 0.001).
Table 1 shows the age and gender distribution of all
household members according to their presence during
the visits. Table 2 shows the reasons for absence in
household members not encountered.
HTC uptake and HIV prevalence
If encountered at home, overall uptake was 85.3%. Table 3
displays likelihood of being encountered at home and
HTC uptake in children, adult women and men. Men and
children were less likely to be encountered at home. But if
encountered, uptake of HTC was similar.
HIV prevalence among those tested was 0.6, 4.2 and
4.0% in children, adult women and adult men, respect-
ively (Table 4). Considering persons encountered at
home who were already known to be HIV positive and
individuals newly diagnosed during home-based HTC,
the prevalence among adults aged 15–49 years was 18.8,
21.6% in women and 13.0% in men.
First-time testers
Among all individuals encountered, 5337 (39.4%) were
first time testers, and 3462 (25.5%) had tested ≥12
months ago. There was a significant difference in the
share of first-time testers between persons tested at first
and second visit (p < 0.001): at first visit 34.8% had never
tested before (second visit: 46.9%), 31.6% had their last
HIV test ≥12months ago (second visit: 28.1%) and
33.7% had tested < 12months ago (24.9%). First time
testers were more likely to uptake HTC compared to
those recently tested (OR: 1.30; 95%CI: 1.16–1.44) and
less likely than those tested > 12months ago (OR: 0.57;
95%CI: 0.50–0.66) (Table 4).
Awareness of HIV status and ART-coverage
Out of the 1765 individuals encountered who were HIV
positive, 1421 (80.5%) already knew their status before
the home-based HTC campaign and 1241 (70.3%) were
already on ART.
Cost estimates
Overall direct costs of the HTC campaigns were USD
137,510; USD 38,322 for senior staff (nurses and cam-
paign organizers); 16,738 for lay-counsellors and drivers;
26,050 for food and accommodation during the cam-
paign as well as small incentives, such as bags, coats and
hats; 30,500 for transport (fuel, vehicle repair and main-
tenance); 25,900 for HIV test kits, IT cost, purchase of
tablets and small equipment, such as gloves, needles, etc.
Overall cost per person tested for HIV, and per person
newly tested HIV positive was USD 11.8 and 399.7, re-
spectively. Costs were higher during weekend catch-up
visits. Per person testing cost were 10.5 and 20.0 during
week and weekend days respectively. Similarly, costs per
person tested HIV positive was lower during weekdays
(335 versus 1056). Differences in cost between weekdays
and weekends were driven by a lower average number of
persons tested per lay-counsellor on weekend days (3.0 vs
6.6) resulting in higher staff-cost relative numbers tested.
Discussion
This study tested the effectiveness of a weekend catch-
up visit to increase home-based HIV testing coverage in
rural and urban areas in Lesotho, Southern Africa. After
a first home-based HTC visit during a work-day, overall
coverage was 62% and increased to 71% after a catch-up
visit during the following weekend. This increase came
at considerable additional cost: Testing a person cost
about twice as much during catch-up visits, and cost per
person newly tested positive was three times higher due
to fewer persons tested per health care worker on week-
ends. During the catch-up visit, 47% were first-time tes-
ters, compared to 35% at the visit. While HTC uptake
was similar between women and men, coverage was sig-
nificantly lower in men due to a higher share of male
household members who were absent at both visits. In
urban areas household members were more likely to be
encountered at home but uptake was lower, resulting in
Table 1 Age and gender of household members
N Encountered at 1st visit Encountered at 2nd visit Not encountered
n 18,336 13,119 1890 3327
Median Age (IQR) 25 (12–45) 28 (14–52) 14 (9–25) 19 (11–34)
Women ≥15 years 7875 6671 (50.9) 459 (24.6) 745 (22.5)
Men≥15 years 4807 3029 (23.1) 436 (23.3) 1342 (40.5)
Children < 15 years 5604 3398 (25.9) 978 (52.2) 1228 (37.0)
Age/sex missing 50 (0.3) 21 (0.2) 17 (0.9) 12 (0.4)
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a slightly lower HTC coverage in the urban areas. Al-
though, in this study, targeted catch-up visits improved
testing coverage, it still fell short of the targeted 90%
testing coverage, mainly because many household mem-
bers were absent at both visits.
To our knowledge, this is the first study quantifying
the added value of targeted catch-up visits after a first
round of home-based HTC. For assessing coverage,
we did not rely on census data or extrapolated esti-
mates but directly censored household-members dur-
ing the campaign. We defined as household members
any person sleeping at least two nights per month in
that household. This broad definition may have led to
a lower HTC coverage compared to other studies. In
the SEARCH project HTC coverage was studied
among “stable residents”, defined as those, “living in
the community for at least 6 months in the past
year”. In Ugandan and Kenyan areas together, the
SEARCH project achieved among adults a 89% HTC
coverage, 86% among men and 92% among women
[18]. Testing coverage among adolescents was 88%
[19]. Another project, conducted in Uganda, calcu-
lated coverage based on official census data. In that
study, during a period of 6 months, 66 trained com-
munity health workers provided home-based HTC to
over 40′000 individuals reflecting an estimated HTC
coverage of 69.4% at the end of the project [20].
Whereas in our study direct cost per person tested
for HIV was USD 11.8 USD and USD 399.7 per
person tested and per person tested HIV positive, re-
spectively. Asiimwe et al. reported from Uganda costs
of USD 3 and 136 per person tested and person
tested positive, respectively [20]. In the SEARCH, pro-
ject home-based HTC was more expensive than com-
munity health campaigns and came at a cost of USD
31.7 per adult tested and 298.5 per adult tested HIV
positive [21]. In line with these reports, our study
shows that home-based HTC is a cost-intensive
approach. On the other hand, home-based HTC re-
mains a good strategy to reach individuals who might
not seek testing at a health facility. In our study,
close to 40% indicated they were testing for the first
time, and 25% stated that their last HIV test was
more than 12 months ago. As demonstrated in
immunization programs previously, increasing cover-
age from an already high coverage to the targeted
90% immunization coverage comes at a higher cost
per percentage than increasing from a lower level to
80% [22]. Similarly, to close the gap from 80 to 90%
HIV testing coverage will need more resources. This
is particularly true for remote rural areas, where find-
ing people living with HIV who are not on treatment
is time- and resource intensive.
For those encountered at home, uptake of HTC was
85.3%. This is lower than in a previous study con-
ducted in the same setting, where 92.5% accepted
HTC [12]. Possible explanations are that the earlier
study provided multi-disease testing and that it was
Fig. 1 Testing coverage after first and second visit
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conducted only in rural areas. In the current study
HTC uptake was substantially lower in urban areas,
resulting in a lower overall coverage. Several studies,
using a multi-disease approach, report uptake rates
for HIV testing over 90% [23–25]. A door to door
HIV testing campaign conducted in neighboring Kwa-
Zulu Natal reports uptake rates of 76 and 86% in
men and women respectively [26]. Of note, in our
study, HTC uptake was similar in men and women
(Table 3) – in contrast to many studies in similar set-
tings, where generally men showed lower acceptance
rates [18, 26]. We are not able to comprehensively
explain the similar HTC acceptance rates among
women and men, but may assume that this is a char-
acteristic of our setting, as we found the same result
in a the previous study [12]. Men were, however,
encountered less often at home, leading to a signifi-
cantly lower HTC coverage among men. They were
mostly absent due to travel, work in the field or work
in neighboring South Africa (Table 2). During the
SEARCH project in Uganda and Kenya, the fact that
men’s labor opportunities often require extended ab-
sences from home was frequently cited as a reason
for lower testing coverage in men [27]. However, ab-
sence on the day of HTC may also have been caused
by men not wanting to test for HIV. As communities
were informed about the HTC campaign in advance,
it is possible that some household members chose
not to be home on the day of the campaign. In order
to target men who were absent during home-based
HTC, social network interventions, self-testing and
testing at the workplace are promising interventions
[28]. Moreover, the recent initiative of male-friendly
clinics where male health care workers provide ser-
vices has shown some first promising results [29].
Another approach may be to leave for household
members who are absent an oral self-test kit [30]. As
for men, it was also difficult to reach school-aged
children. One approach might be to provide large-
scale school-based HTC. In a survey in South Africa,
over 90% of parents supported HIV testing at schools
[31].
Despite Lesotho having the second-highest HIV
prevalence in the world, yield of new HIV diagnoses
in our study was low with 4.2 and 4.0% in women
and men respectively. However, considering all those
encountered who already knew about their positive
HIV status, adult prevalence in the population
assessed was 18.8%, which is similar to the reported
adult HIV prevalence in Butha-Buthe of 17.8% [15].
In line with the Lesotho population-based impact as-
sessment (LePHIA) [15], our findings indicate that
already in 2016 about 80% of HIV infected persons
knew their status and 70% are taking ART. The en-
couraging fact that Lesotho is progressing towards the
90–90-90 targets, decreases the yield of newly tested
positive individuals during home-based testing. Con-
sidering the yield of new HIV diagnoses, home-based
testing may thus not be an efficient approach any-
more [32]. However, several studies indicated that the
benefit of home-based HTC should not only be seen
in numbers newly found HIV positive as a negative
HIV test may increase awareness and reduce risk-
behavior [33]. Moreover, as indicated by high shares
of first-time testers in our study, home-based HTC
remains a valid approach to test persons who might
not access testing otherwise. Furthermore, home-
based HTC may serve to re-engage individuals who
are known HIV positive but who never linked to care
or dis-engaged from care. Furthermore, home-based
Table 2 Reasons for not being at home at first and second
visit among household members not encountered (29 are
not included in the table due to missing information about
sex or age)
Location of absent household members First visit Second visit
Women ≥15 years 1204 745
– At school 318 (26.4) 197 (26.4)
– Work, commuting daily 148 (12.3) 115 (15.4)
– Work, home on weekends 44 (3.7) 36 (4.8)
– Work in South Africa 84 (7.0) 80 (10.7)
– In the fields/herding 36 (3.0) 22 (3.0)
– Single day absence (not work-related) 386 (32.1) 256 (34.4)
– On holidays 23 (1.9) 20 (2.7)
– No information 165 (3.7) 19 (2.6)
Men ≥15 years 1778 1342
– At school 277 (15.6) 193 (14.4)
– Work, commuting daily 178 (10.0) 140 (10.4)
– Work, home on weekends 69 (3.9) 59 (4.4)
– Work in South Africa 250 (14.1) 231 (17.2)
– In the fields/herding 465 (26.2) 373 (27.8)
– Single day absence (not work-related) 417 (23.5) 322 (24.0)
– On holidays 19 (1.1) 17 (1.3)
– No information 103 (5.8) 7 (0.5)
Children 2206 1228
– At school 1657 (75.1) 981 (79.9)
– Work, commuting daily 5 (0.2) 2 (0.2)
– Work, home on weekends 2 (0.1) 2 (0.2)
– Work in South Africa 3 (0.1) 3 (0.2)
– In the fields/herding 85 (3.9) 62 (5.1)
– Single day absence (not work-related) 244 (11.1) 161 (13.1)
– Away on holiday 14 (0.6) 12 (1.0)
– No information 196 (8.9) 5 (0.4)
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HIV testing may be combined with services address-
ing other conditions, such as mother-and-child health,
tuberculosis, mother-and-child health, and screening
for viral hepatitis and other sexually transmitted
diseases.
This study has several limitations. First, for calculating
coverage, we used a broader definition of household
member than earlier studies, and censoring of absent
household members relied on reporting from those
members who were found at home. Second, household
members not encountered may well have been tested for
HIV on another occasion, i.e. at their workplace in
South Africa or at one of numerous testing-points
within Lesotho. Finally, previous testing history relied on
interviews and on information found in the health book-
lets of the household members.
Conclusions
In summary, during home-based HIV testing
campaigns, a second catch-up visit during the weekend
increased testing coverage in the whole community by
about 9% and reached more first-time testers. However,
the weekend catch-up visit increased cost per person
tested and per person newly tested HIV positive consid-
erably. Overall, even with a catch-up visit, testing
coverage in the assessed communities fell short of the
targeted 90%. More research is needed about how to
design more cost-effective HTC campaigns with a
particular emphasis on providing different approaches
for different population groups, e.g. by combining com-
munity- and home-based testing or introducing self-
testing for those household members not encountered
at home or refusing to test.
Table 4 HTC uptake and HIV prevalence among household members encountered at home who were not known to be HIV
positive
Na HTC uptake % OR (95%CI) p-value Tested HIV+ (%) OR (95%CI) p-value
Women ≥15 years 6110 84.2 4.2
Never tested 1499 81.3 Ref 4.3
< 12 months ago 2903 82.2 1.06 (0.90–1.25) 0.46 3.1 0.72 (0.50–1.03) 0.07
≥ 12months ago 1677 91.2 2.37 (1.92–2.94) < 0.001 6.0 1.42 (1.00–2.01) 0.05
Men ≥15 years 3130 83.5 4.0
Never tested 1188 82.0 Ref 4.6
< 12 months ago 901 77.8 0.77 (0.62–0.96) 0.02 2.7 0.58 (0.33–0.99) 0.05
≥ 12months ago 1016 91.2 2.29 (1.76–2.98) < 0.001 4.4 0.96 (0.62–1.48) 0.84
Children < 15 years 4314 88.5 0.6
Never tested 2650 89.3 Ref 0.8
< 12 months ago 863 85.1 0.68 (0.55–0.85) 0.001 0 –
≥ 12months ago 769 91.0 1.20 (0.91–1.56) 0.20 0.3 0.35 (0.08–1.53) 0.16
aFrom the total number, time since last HIV test was missing for 31 women, 25 men, and 32 children
Table 3 Likelihood of being encountered at home and HTC uptake according to age and gender
Total n n (%) Odds-ratio (95%CI) p-value
Total HH members 18,286a
Ever encountered at home
– Women ≥15 years 7875 7130 (90.5) 1
– Men ≥15 years 4807 3465 (72.1) 0.27 (0.24–0.30) < 0.001
– Children < 15 years 5604 4376 (78.1) 0.37 (0.33–0.41) < 0.001
HTC Uptake if encountered and not known HIV positive 13,554 11,592 (85.3)
– Women ≥15 years 6119 5144 (84.2) 1
– Men ≥15 years 3130 2613 (83.5) 0.95 (0.84–1.07) 0.38
– Children < 15 years 4314 3816 (88.5) 1.44 (1.28–1.62) < 0.001
HTC coverage after 2 visits 18,286a 12,991 (71.0)
– Women ≥15 years 7875 6165 (78.3) 1
– Men ≥15 years 4807 2948 (61.3) 0.44 (0.41–0.48) < 0.001
– Children < 15 years 5604 3878 (69.2) 0.62 (0.58–0.67) < 0.001
a50 individuals were excluded from the table due to missing information on gender and/or age
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